Global research antibodies and reagents market is projected to witness a CAGR of 7.08% during the forecast period 2024-2031F, growing from USD 12.63 billion in 2023 to USD 21.82 billion in 2031F. The market has experienced significant growth in recent years and is expected to maintain a strong pace of expansion in the coming years.
Growth in the global research antibodies and reagents market is driven by various factors, such as the increasing prevalence of chronic diseases and infectious diseases, the growing cell and gene therapy market, technological advancements, and increased investments by the government and other related industries to conduct research and development activities. Moreover, the presence of several leading players, collaborative ventures, and growing interest in the biopharmaceutical and biotechnological industry accelerates the global research antibodies and reagents market growth.
Antibodies and reagents are widely used to diagnose and treat various chronic diseases, such as autoimmune diseases, cancers, and infections. Due to this, there is increased demand for research in the antibodies and reagents market. Technological advancements such as the application of artificial intelligence (AI) enable researchers to improve the quality of antibodies and reagents testing and validation. Growth in the life science industry, such as the biopharmaceutical and drug development industries, along with increased investments and funding by the government and related industries, are the factors leading to market growth. Moreover, frequent and consistent collaboration activities such as mergers and acquisitions and partnership agreements to increase research in this market further propel the global research antibodies and reagents market.
Increasing Prevalence of Chronic Diseases
The demand for research in antibodies and reagents is increasing significantly due to the rising prevalence of chronic diseases. The increasing aging population is responsible for the onset of several chronic health conditions such as infections, cardiovascular diseases, cancer, and autoimmune diseases. These fatal chronic diseases need continuous research and development activities to bring diagnostics measures and innovative therapeutics. According to WHO 2023 statistics, chronic diseases are the most common diseases affecting people from all over the world and are responsible for 41 million deaths every year worldwide. A sedentary lifestyle, unhealthy diet, obesity, and excessive tobacco and alcohol consumption are the leading risk factors for the rising prevalence of chronic diseases among the population. The insufficient availability of successful therapies for chronic illnesses has increased emphasis on bringing effective and efficient pharmaceuticals and innovative diagnostics and treatments, consequently increasing the necessity for conducting advanced research in the antibodies and reagents industry. Due to all these factors, the global research antibodies and reagents market is flourishing.
Technological Advancements
Technological advancements in research antibodies and reagents are rapidly evolving, leading to tremendous growth in the research antibodies and reagents market. Technological advancements such as the development of CRISPR-Cas9 and single-cell analysis are increasing the demand, due to which several leading players are developing innovative product launches to accelerate advancements and growth in this industry. For instance, in December 2023 Cytek Biosciences, Inc., a leading biotechnology company, announced its latest launch “Cytek Orion”, which is a reagent cocktail preparation system. It is an innovative fully automated reagent cocktailing technology that eases the laboratory workflow, leading to satisfactory results, enhancing accuracy, and speeding up the production process. This new system can mix and manage cocktail mixtures consisting of as many as 60 distinct reagent antibody conjugates. Due to these innovations and advancements, the global research antibodies and reagents market is expected to flourish in the forecasted period.
Immunohistochemistry Holds a Significant Market Share
Based on technology, immunohistochemistry holds a significant market share as it is the most preferred diagnostic test for diseases such as cancer and it is estimated that its use is significantly increasing with the increasing demand for personalized medicine. Frequent antibodies and reagents launched by the leading biopharmaceutical companies to accelerate application in immunohistochemistry technologies are leading to the faster growth of this technology. For instance, in March 2023, Aptamer Group plc, a leading provider of custom optimer selection and development services, announced the launch of a new reagent known as “Optimer-Fc”, for application in automated immunohistochemistry (IHC) workflows. These innovative and potential product launches by key market players are accelerating the market growth.
Increased Application in Proteomics
Based on application, proteomics holds the maximum market share due to its technological advancements and potential in preparing personalized medicines. Due to its higher demand in the industry, several leading players are launching innovative products in this segment. For instance, in July 2023, Alfa Chemistry, a well-known chemical supplier, announced the launch of various proteomics products that will enhance life science research in the healthcare industry. These high-quality proteomics products, including staining reagents, western substrate, and TMB ELISA substrates are extensively used in protein analysis. These frequent product launches lead to escalating research activities in proteomics contributing to the overall market growth.
Asia-Pacific is Expected to be the Fastest-growing Region
Asia-Pacific is expected to be the fastest-growing region in the global research antibodies and reagents market. The rapidly increasing population and prevalence of chronic and infectious diseases in this region are accelerating the demand for increased research and development activities in developing efficient antibodies and reagents to improve drug discovery and enhance medical facilities. Asia-Pacific is an emerging market that has huge potential in the life science industry, due to which key market players are continuously developing partnership collaborations and establishing research institutes in this region to enhance research and development in this market. For instance, in September 2023, Agilent Technologies Inc. announced that it would partner with Advanced Cell Therapy and Research Institute in Singapore for three years. This partnership aims to bring innovation and advancement and enhance research studies in the field of cell and gene therapy. These collaborations within the Asia-Pacific are flourishing in the research antibodies and reagents market in this region.
Future Market Scenario (2024–2031F)
The global research antibodies and reagents market is expected to grow due to several factors. The increasing prevalence of chronic diseases worldwide is accelerating the demand for extensive research activities in the antibodies and reagents market to bring innovation and advancement in the healthcare sector. Technological advancements, such as the application of AI to ease the research process in this market, along with increased investments and funds by the government and life science industry are leading to escalating growth. Additionally, frequent collaboration activities such as partnerships to enhance research studies in this market are expected to flourish the global research antibodies and reagents market in the forecast period.
For instance, in February 2023, Bio-Techne Corporation and Cell Signaling Technology, both life science companies announced the partnership to add Simple Western validation to CST antibodies. This approach will enable researchers from different disciplines to study the molecular signaling pathways easily by using this simple Western validation platform.
Report Scope
“Research Antibodies and Reagents Market Assessment, Opportunities and Forecast, 2017-2031F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of global research antibodies and reagents market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecast between 2024 and 2031F. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.